In recent years, Lund-based biotech Abliva has made great progress with its two candidates in primary mitochondrial diseases. To understand more about mitochondrial diseases, BioStock spoke to the company's Chief Medical Officer Magnus Hansson.

Read the article at biostock.se:

https://www.biostock.se/en/2022/08/a-new-approach-to-mitochondrial-diseases/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

https://news.cision.com/abliva/r/biostock-a-new-approach-to-mitochondrial-diseases,c3612223

(c) 2022 Cision. All rights reserved., source Press Releases - English